Safilens, the Italian contact lens company acquired by a pharmaceutical group in Rome two years ago, is working on processes that will allow its lenses to release vitamins and actual drugs into the eye. It is particularly keen on developing a process for the release of a beta blocker that ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.